Erschienen in:
13.07.2022 | Research Letter
Bleeding risk in patients with autosomal dominant polycystic kidney disease treated with acetylsalicylic acid: implications for prevention of preeclampsia
verfasst von:
M. F. C. de Jong, H. M. Komdeur, M. Salih, E. Meijer, the DIPAK consortium
Erschienen in:
Journal of Nephrology
|
Ausgabe 9/2022
Einloggen, um Zugang zu erhalten
Excerpt
Recent guidelines on pregnancy in Chronic Kidney Disease (CKD) advocate prescription of acetylsalicylic acid to decrease the incidence of preeclampsia (PE) [
1]. However, when a 30-year-old pregnant woman (G1P0), with autosomal dominant polycystic kidney disease (ADPKD) and acetylsalicylic acid use for PE prevention, presented at the emergency room with a kidney cyst bleed, we questioned whether low-dose acetylsalicylic acid should systematically be prescribed in pregnant ADPKD patients. …